Article Details

Roche inks $110m allogeneic CAR-T deal with Poseida - BioProcess International

Retrieved on: 2022-08-05 16:24:28

Tags for this article:

Click the tags to see associated articles and topics

Roche inks $110m allogeneic CAR-T deal with Poseida - BioProcess International. View article details on hiswai:

Excerpt

Roche has jumped deeper into the allogeneic cell therapy space through a CAR-T collaboration and license deal with Poseida Therapeutics.

Article found on: bioprocessintl.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up